Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2025 04:01 ET | Source: Research and Markets

Psoriatic Arthritis Market Report 2025-2035 | Competitive Analysis of AbbVie, UCB, Pfizer, Johnson & Johnson, Eli Lilly and Co, Bristol-Myers Squibb, Affibody, Amgen, Boehringer Ingelheim, Sun Pharma

Dublin, July 11, 2025 (GLOBE NEWSWIRE) -- The "Psoriatic Arthritis Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035" report has been added to...
June 24, 2025 05:22 ET | Source: Research and Markets

Kinase Inhibitors in Autoimmune Diseases Research Report 2025-2035 | Market Accelerates Amid Rising Disease Prevalence, Kinase Innovation, and Demand for Safer Treatments

Dublin, June 24, 2025 (GLOBE NEWSWIRE) -- The "Kinase Inhibitors in Autoimmune Diseases Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast,...
March 04, 2025 10:27 ET | Source: Research and Markets

Janus Kinase (JAK) Inhibitor Pipeline Market Insights Report 2025: Comprehensive Review of 50+ Companies and Respective 55+ Drugs

Dublin, March 04, 2025 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2025" drug pipelines has been added to ResearchAndMarkets.com's offering.The "Janus Kinase (JAK)...
January 21, 2025 08:00 ET | Source: Research and Markets

Atopic Dermatitis Drugs Market Trends Analysis Report 2025-2030: Atopic Dermatitis Treatment Surges with 9.02% CAGR, Pushing Worldwide Market Near USD 30 Billion

Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Atopic Dermatitis Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region,...
August 15, 2024 11:04 ET | Source: Research and Markets

Janus Kinase (JAK) Inhibitor Therapeutic Report 2024: Strategic Evaluation of Over 50 Companies and 55+ Pipeline Drugs

Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...